IGMS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Igm Biosciences Inc (IGMS).


$363.33M Market Cap.

As of 03/06/2025 5:00 PM ET (MRY) • Disclaimer

IGMS Market Cap. (MRY)


IGMS Shares Outstanding (MRY)


IGMS Assets (MRY)


Total Assets

$265.71M

Total Liabilities

$217.54M

Total Investments

$157.29M

IGMS Income (MRY)


Revenue

$2.68M

Net Income

-$195.79M

Operating Expense

$211.26M

IGMS Cash Flow (MRY)


CF Operations

-$153.00M

CF Investing

$64.16M

CF Financing

$2.39M

IGMS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

IGMS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$265,712,000 (-37.24%)

$423,411,000 (-17.54%)

$513,499,000 (72.24%)

$298,127,000 (-27.04%)

Assets Current

$193,620,000 (-44.30%)

$347,597,000 (-20.72%)

$438,421,000 (82.11%)

$240,747,000 (-35.50%)

Assets Non-Current

$72,092,000 (-4.91%)

$75,814,000 (0.98%)

$75,078,000 (30.84%)

$57,380,000 (62.27%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$48,172,000 (-76.30%)

$203,234,000 (-29.25%)

$287,263,000 (17.29%)

$244,908,000 (-35.86%)

Property Plant & Equipment Net

$71,033,000 (-4.02%)

$74,005,000 (1.27%)

$73,075,000 (29.69%)

$56,344,000 (61.85%)

Cash & Equivalents

$26,662,000 (-76.43%)

$113,112,000 (-7.22%)

$121,920,000 (-9.04%)

$134,035,000 (-44.40%)

Accumulated Other Comprehensive Income

$159,000 (5.30%)

$151,000 (121.54%)

-$701,000 (-962.12%)

-$66,000 (-353.85%)

Deferred Revenue

$144,122,000 (-1.82%)

$146,801,000 (-1.43%)

$148,931,000 (0%)

$0 (0%)

Total Investments

$157,292,000 (-30.14%)

$225,157,000 (-26.40%)

$305,931,000 (217.99%)

$96,208,000 (-23.15%)

Investments Current

$157,292,000 (-30.14%)

$225,157,000 (-26.40%)

$305,931,000 (217.99%)

$96,208,000 (-23.15%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$983,000 (-25.87%)

$1,326,000 (-47.21%)

$2,512,000 (-55.01%)

$5,584,000 (-29.53%)

Accumulated Retained Earnings (Deficit)

-$1,017,037,000 (-23.84%)

-$821,242,000 (-42.87%)

-$574,826,000 (-62.51%)

-$353,724,000 (-87.59%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$45,186,000 (11.55%)

$40,506,000 (-1.62%)

$41,172,000 (43.16%)

$28,759,000 (134.88%)

Debt Current

$7,121,000 (22.06%)

$5,834,000 (0.31%)

$5,816,000 (75.18%)

$3,320,000 (24.48%)

Debt Non-Current

$38,065,000 (9.79%)

$34,672,000 (-1.93%)

$35,356,000 (38.98%)

$25,439,000 (165.63%)

Total Liabilities

$217,540,000 (-1.20%)

$220,177,000 (-2.68%)

$226,236,000 (325.10%)

$53,219,000 (98.45%)

Liabilities Current

$37,638,000 (-11.40%)

$42,481,000 (-4.93%)

$44,685,000 (60.85%)

$27,780,000 (61.14%)

Liabilities Non-Current

$179,902,000 (1.24%)

$177,696,000 (-2.12%)

$181,551,000 (613.67%)

$25,439,000 (165.63%)

IGMS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$2,679,000 (25.77%)

$2,130,000 (99.25%)

$1,069,000 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$50,405,000 (0.67%)

$50,072,000 (0.68%)

$49,736,000 (29.87%)

$38,297,000 (109.85%)

Research & Development Expense

$160,854,000 (-25.36%)

$215,519,000 (20.21%)

$179,289,000 (41.14%)

$127,026,000 (95.33%)

Operating Expenses

$211,259,000 (-20.46%)

$265,591,000 (15.97%)

$229,025,000 (38.53%)

$165,323,000 (98.51%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$678,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$195,795,000 (20.54%)

-$246,416,000 (-11.45%)

-$221,102,000 (-33.87%)

-$165,164,000 (-103.02%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$195,795,000 (20.54%)

-$246,416,000 (-11.45%)

-$221,102,000 (-33.87%)

-$165,164,000 (-103.02%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$195,795,000 (20.54%)

-$246,416,000 (-11.45%)

-$221,102,000 (-33.87%)

-$165,164,000 (-103.02%)

Weighted Average Shares

$60,514,546 (15.68%)

$52,311,958 (25.92%)

$41,543,954 (24.09%)

$33,479,782 (8.88%)

Weighted Average Shares Diluted

$60,514,546 (15.68%)

$52,311,958 (25.92%)

$41,543,954 (24.09%)

$33,479,782 (8.88%)

Earning Before Interest & Taxes (EBIT)

-$195,795,000 (20.32%)

-$245,738,000 (-11.14%)

-$221,102,000 (-33.87%)

-$165,164,000 (-103.02%)

Gross Profit

$2,679,000 (25.77%)

$2,130,000 (99.25%)

$1,069,000 (0%)

$0 (0%)

Operating Income

-$208,580,000 (20.83%)

-$263,461,000 (-15.58%)

-$227,956,000 (-37.89%)

-$165,323,000 (-98.51%)

IGMS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$64,158,000 (-6.14%)

$68,355,000 (130.29%)

-$225,644,000 (-1559.44%)

$15,461,000 (-73.48%)

Net Cash Flow from Financing

$2,388,000 (-97.92%)

$115,068,000 (-47.55%)

$219,382,000 (8760.34%)

$2,476,000 (-98.85%)

Net Cash Flow from Operations

-$152,996,000 (20.41%)

-$192,231,000 (-3184.32%)

-$5,853,000 (95.32%)

-$124,982,000 (-84.12%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$86,450,000 (-881.49%)

-$8,808,000 (27.30%)

-$12,115,000 (88.68%)

-$107,045,000 (-152.17%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$69,971,000 (-13.33%)

$80,736,000 (137.48%)

-$215,438,000 (-850.52%)

$28,705,000 (-62.13%)

Capital Expenditure

-$5,813,000 (53.05%)

-$12,381,000 (-21.31%)

-$10,206,000 (22.94%)

-$13,244,000 (24.33%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$2,460,000 (-97.86%)

$115,068,000 (-47.55%)

$219,382,000 (5342.37%)

$4,031,000 (-98.14%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$38,266,000 (-17.79%)

$46,547,000 (4.11%)

$44,710,000 (72.81%)

$25,873,000 (206.04%)

Depreciation Amortization & Accretion

$14,408,000 (5.24%)

$13,691,000 (29.14%)

$10,602,000 (37.26%)

$7,724,000 (116.00%)

IGMS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00%

-

Profit Margin

-7308.50% (36.83%)

-11568.80% (44.07%)

-20683.10%

-

EBITDA Margin

-6770.70% (37.85%)

-10894.20% (44.68%)

-19691.30%

-

Return on Average Equity (ROAE)

-190.70% (-84.79%)

-103.20% (-39.46%)

-74.00% (-35.28%)

-54.70% (-68.31%)

Return on Average Assets (ROAA)

-61.00% (-14.02%)

-53.50% (-14.56%)

-46.70% (3.71%)

-48.50% (-62.75%)

Return on Sales (ROS)

-7308.50% (36.65%)

-11537.00% (44.22%)

-20683.10%

-

Return on Invested Capital (ROIC)

-72.50% (7.64%)

-78.50% (-12.95%)

-69.50% (40.50%)

-116.80% (-168.51%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.89 (-6.92%)

-1.76 (44.82%)

-3.2 (46.26%)

-5.95 (82.14%)

Price to Sales Ratio (P/S)

138.02 (-32.37%)

204.09 (-69.13%)

661.05

-

Price to Book Ratio (P/B)

7.54 (215.83%)

2.39 (-5.84%)

2.54 (-34.77%)

3.89 (-45.23%)

Debt to Equity Ratio (D/E)

4.52 (316.99%)

1.08 (37.44%)

0.79 (263.13%)

0.22 (210.00%)

Earnings Per Share (EPS)

-3.24 (31.21%)

-4.71 (11.47%)

-5.32 (-7.91%)

-4.93 (-86.04%)

Sales Per Share (SPS)

0.04 (7.32%)

0.04 (57.69%)

0.03 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.62 (32.91%)

-3.91 (-910.59%)

-0.39 (90.63%)

-4.13 (-48.69%)

Book Value Per Share (BVPS)

0.8 (-79.51%)

3.88 (-43.82%)

6.92 (-5.47%)

7.32 (-41.09%)

Tangible Assets Book Value Per Share (TABVPS)

4.39 (-45.75%)

8.09 (-34.51%)

12.36 (38.80%)

8.9 (-32.99%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (-100.00%)

-1 (66.67%)

-3 (40.00%)

-5 (84.85%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.02 (-33.38%)

-1.51 (44.94%)

-2.75 (46.97%)

-5.18 (85.05%)

Asset Turnover

0.01 (60.00%)

0.01 (150.00%)

0 (0%)

0 (0%)

Current Ratio

5.14 (-37.13%)

8.18 (-16.60%)

9.81 (13.21%)

8.67 (-59.98%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$158,809,000 (22.39%)

-$204,612,000 (-1174.13%)

-$16,059,000 (88.38%)

-$138,226,000 (-61.89%)

Enterprise Value (EV)

$366,118,146 (4.30%)

$351,033,605 (-39.31%)

$578,451,952 (-29.10%)

$815,876,984 (-69.74%)

Earnings Before Tax (EBT)

-$195,795,000 (20.32%)

-$245,738,000 (-11.14%)

-$221,102,000 (-33.87%)

-$165,164,000 (-103.02%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$181,387,000 (21.83%)

-$232,047,000 (-10.24%)

-$210,500,000 (-33.70%)

-$157,440,000 (-102.42%)

Invested Capital

$246,598,000 (-20.02%)

$308,324,000 (-20.55%)

$388,066,000 (135.09%)

$165,071,000 (1.55%)

Working Capital

$155,982,000 (-48.88%)

$305,116,000 (-22.51%)

$393,736,000 (84.88%)

$212,967,000 (-40.18%)

Tangible Asset Value

$265,712,000 (-37.24%)

$423,411,000 (-17.54%)

$513,499,000 (72.24%)

$298,127,000 (-27.04%)

Market Capitalization

$363,326,146 (-25.13%)

$485,254,605 (-33.39%)

$728,478,952 (-23.49%)

$952,101,984 (-64.87%)

Average Equity

$102,682,500 (-57.00%)

$238,783,250 (-20.10%)

$298,842,000 (-1.09%)

$302,137,500 (20.74%)

Average Assets

$320,713,250 (-30.32%)

$460,290,250 (-2.81%)

$473,593,250 (39.14%)

$340,373,500 (24.62%)

Invested Capital Average

$270,130,500 (-13.66%)

$312,875,500 (-1.63%)

$318,047,750 (124.98%)

$141,369,000 (-24.39%)

Shares

59,464,181 (1.83%)

58,394,056 (36.35%)

42,826,511 (31.93%)

32,461,711 (5.74%)